The primary defect of beta‐oxidation pathway in MADD patients is due to gene defects leading to alteration of ETFDH stability/folding, somehow related to FAD availability.13, 25. This evidence concerns the gene ETFDH and multiple acyl-CoA dehydrogenase deficiency.